# Neotropix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neotropix

- Industry: Biotechnology
- Headquarters: Malvern, US
- Website: www.neotropix.com
- Total disclosed funding: $14M
- Latest round: Series B (May 1, 2009)
- Investors on record: 3

## About

Founded in 2003, Neotropix is a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers.

## Funding rounds

- Series B, May 1, 2009, $1.4M — Aurora Funds, VIMAC Ventures, Quaker Partners Management
- Series A, Apr 2, 2008, $2M — Aurora Funds, VIMAC Ventures, Quaker Partners Management
- Series A, Dec 21, 2006, $0.9M — Aurora Funds
- Series A, Dec 13, 2004, $10M — Aurora Funds, VIMAC Ventures, Quaker Partners Management

## Investors

- Aurora Funds (https://capitalatlas.ai/funds/aurora-funds) — Series A, Series B
- VIMAC Ventures (https://capitalatlas.ai/funds/vimac-ventures) — Series A, Series B
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A, Series B